Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05810025 · ClinicalTrials.gov registry record · NA
FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT05810025 is a NA study that has completed, run by Columbia University. The registered enrollment target is 70 participants.
The verdict
NCT05810025, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
Electronic health records (EHRs) are an increasingly common source for populating risk models, but whether used to populate validated risk assessment models or to de-facto build risk prediction models, EHR data presents several challenges. The purpose of this study is to assess how the integration of patient generated health data (PGHD) and EHR data can generate more accurate risk prediction models, advance personalized cancer prevention, improve digital access to health data in an equitable manner, and advance policy goals for Patient Generated Health Data (PGHD) and EHR interoperability.
Interventions
- BEHAVIORAL RealRisks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05810025
The ClinicalTrials.gov registry entry for NCT05810025 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RealRisks is the first listed.
NCT05810025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05810025 about?
NCT05810025 is a clinical study titled "FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments". Electronic health records (EHRs) are an increasingly common source for populating risk models, but whether used to populate validated risk assessment models or to de-facto build risk prediction models, EHR data presents several challenges. The purpose of this study is to assess how the integration o...
What is the current status of trial NCT05810025?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2023-05-01. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT05810025?
The interventions under investigation include: RealRisks (BEHAVIORAL).
Who is sponsoring clinical trial NCT05810025?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.